HEMEDEX INCORPORATED

HEMEDEX INC., founded in 2000, commercializes proprietary MIT-derived technology for real-time quantification of tissue perfusion and cerebral blood flow (CBF) at the capillary level. The company's patented thermal diffusion microprobe-based platform is designed for use in neurocritical care and neurosurgical settings, providing clinicians with continuous, absolute measurements of cerebral perfusion during complex procedures involving compromised vasculature, traumatic brain injury, subarachnoid hemorrhage, and other acute neurological conditions. The Bowman Perfusion Monitor enables bedside multimodal neuromonitoring for up to ten days, offering early warning of tissue ischemia and rapid assessment of intervention efficacy. ISO 13485:2012 certified medical device manufacturer serving leading academic medical centers and neuro ICUs across North America.